• Home
  • Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.

Author List
Litton JK, Rugo HS, Ettl J, Hurvitz SA, Gonçalves A, Lee KH, Fehrenbacher L, Yerushalmi R, Mina LA, Martin M, Roché H, Im YH, Quek RGW, Markova D, Tudor IC, Hannah AL, Eiermann W, Blum JL
Publication
The New England journal of medicine
Publication ID (Profile URL)
https://researcherprofiles.org/profile/24430386
Publication Year
2018
PubMed ID
30110579
Publication Title
Litton JK, Rugo HS, Ettl J, Hurvitz SA, Gonçalves A, Lee KH, Fehrenbacher L, Yerushalmi R, Mina LA, Martin M, Roché H, Im YH, Quek RGW, Markova D, Tudor IC, Hannah AL, Eiermann W, Blum JL. Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation. N Engl J Med. 2018 08 23; 379(8):753-763.